GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Venmax Drugs and Pharmaceuticals Ltd

Venmax Drugs: 21.47 Lakh Equity Shares Allotted from Warrant Conversion

FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 29 Jul 2026, 07:24 PM IST  ·  BSE ID: 3be7e9ab-bf76-4fe7-a9aa-2092f0b424c5
View Original BSE Filing (PDF)
💡
In Simple Terms
The company issued new shares to people who already held special options, raising capital and increasing its total share value.
🤖 AI Summary
  • Venmax Drugs allotted 21,47,665 equity shares from convertible warrant conversion.
  • Allotment made at Rs. 20 per share, including Rs. 10 premium.
  • Rs. 3.22 Crore collected as balance exercise price for warrants.
  • Company's paid-up capital increased to Rs. 13,73,05,950.
  • Eight warrant holders converted their holdings into shares.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity Shares Allotted
21,47,665
Issue Price per Share
Rs. 20/-
Premium per Share
Rs. 10/-
Balance Exercise Price Collected
Rs. 3,22,14,975/-
Post-Allotment Paid-up Capital
Rs. 13,73,05,950/-
Post-Allotment Equity Shares
1,37,30,595
🏢 How This Affects the Company
📈
Business Impact
The conversion of warrants into equity shares injects capital into the company, strengthening its financial position. This capital can be used for business operations and potential expansion.
💰
Financial Impact
The company's paid-up capital has increased to Rs. 13,73,05,950 post-allotment. This infusion of funds from warrant holders impacts the balance sheet by increasing equity.
⚠️
Risk Impact
The increase in share capital through warrant conversion can dilute existing shareholder percentages if they do not participate in future issuances. However, it provides funds for operational stability.
👥 What This Means For Shareholders
✅
Action Required
No specific action is required from existing shareholders regarding this allotment.
👤
Who Is Affected
Shareholders whose holdings are diluted by the issuance of 21,47,665 new equity shares.
🔍
Management Signal
Management is executing its prior decisions on preferential allotment to strengthen the company's capital structure.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Future quarterly results to assess capital deployment.
Disclosure on utilisation of Rs. 3.22 Crore raised.
Any further warrant conversions or equity issuances.
LOW RISK This filing represents the execution of a prior decision, with no new inherent risks.
💡 Investor Takeaway
Venmax Drugs converted 21,47,665 warrants into equity shares at Rs. 20 each, raising Rs. 3.22 Crore and increasing paid-up capital to Rs. 13,73,05,950.
⚖️ Strengths & Concerns

✅ Positives

  • Successful conversion of 21,47,665 warrants into equity shares, strengthening capital base.
  • Collection of Rs. 3,22,14,975 in balance exercise price, enhancing liquidity.

⚠️ Concerns

  • Dilution of shareholding for non-participating existing shareholders due to new equity issuance.
  • No prior period financial data is available for comparison in this filing.
📅 Company Track Record
Previously, on March 23, 2026, Venmax Drugs allotted 28,00,000 equity shares from warrant conversion, collecting Rs. 4.20 Crore, with 36,81,000 warrants remaining outstanding.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
How many equity shares did Venmax Drugs allot from warrant conversion?
Venmax Drugs allotted 21,47,665 equity shares upon conversion of convertible warrants.
What was the issue price for the newly allotted equity shares?
The equity shares were allotted at an issue price of Rs. 20/- each, comprising Rs. 10/- face value and Rs. 10/- premium.
How much capital did Venmax Drugs raise from this warrant conversion?
The company collected Rs. 3,22,14,975/- as the balance exercise price for the warrants converted.
What is the new paid-up capital of Venmax Drugs after this allotment?
The company's paid-up capital has increased to Rs. 13,73,05,950/-.
Who were the allottees of these equity shares?
The equity shares were allotted to eight non-promoter warrant holders, including Dinesh Dayaram Dhanak & Deepti Dinesh Dhanak (Joint Holders), Nitesh Niranjan Jha, and Umesh Bikhchand Bijlani, among others.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.